Literature DB >> 7641347

Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters.

E B Williams1, I Halpert, S Wickline, G Davison, W C Parks, J N Rottman.   

Abstract

BACKGROUND: Osteopontin, a noncollagenous matrix protein, is transiently expressed in the heart after experimental cardiac injury, but its expression in states of continuing cardiac remodeling is unknown. We evaluated osteopontin expression in the heritable cardiomyopathy of the Syrian hamster. METHODS AND
RESULTS: Hamster hearts were obtained for RNA isolation and analysis and in situ hybridization from two groups: normal control animals (n = 4) and untreated cardiomyopathic hamsters (n = 5). Osteopontin mRNA was 12-fold greater in cardiomyopathic hearts compared with normal controls (1.76 +/- 0.31 versus 0.14 +/- 0.04 arbitrary units normalized to GAPDH, mean +/- SEM, P < .05). In situ hybridization was used to define the origin of osteopontin in the heart. Osteopontin mRNA above background levels was not detected in sections from noncardiomyopathic hamster hearts but was readily detected in sections from cardiomyopathic hamsters, in which it originated in cells morphologically consistent with tissue macrophages.
CONCLUSIONS: In the hamster, osteopontin is expressed in heritably cardiomyopathic hearts under conditions of chronic injury and repair, and the source of ostopontin message appears to be issue macrophage-like cells in foci of inflammation. This model could be used to evaluate the biological role of osteopontin in myocardial inflammation and remodeling.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641347     DOI: 10.1161/01.cir.92.4.705

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction.

Authors:  N Ashizawa; K Graf; Y S Do; T Nunohiro; C M Giachelli; W P Meehan; T L Tuan; W A Hsueh
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

2.  Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy.

Authors:  Manolis Mavroidis; Yassemi Capetanaki
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 3.  Role of osteopontin in heart failure associated with aging.

Authors:  Mahipal Singh; Cerrone R Foster; Suman Dalal; Krishna Singh
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

4.  Extracellular matrix remodelling in myocardial hypertrophy and failure : focus on osteopontin.

Authors:  Pietro Francia; Arianna Uccellini; Alessandra Frattari; Anna Modestino; Agnese Ricotta; Cristina Balla; Ludovica Scialla; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

Review 5.  Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI.

Authors:  Mahipal Singh; Cerrone R Foster; Suman Dalal; Krishna Singh
Journal:  J Mol Cell Cardiol       Date:  2009-06-30       Impact factor: 5.000

6.  Cardiac structural and hemodynamic changes associated with physiological heart hypertrophy of pregnancy are reversed postpartum.

Authors:  Soban Umar; Rangarajan Nadadur; Andrea Iorga; Marjan Amjedi; Humann Matori; Mansoureh Eghbali
Journal:  J Appl Physiol (1985)       Date:  2012-08-23

7.  Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stress.

Authors:  Suman Dalal; Qinqin Zha; Christopher R Daniels; Rebecca J Steagall; William L Joyner; Alain-Pierre Gadeau; Mahipal Singh; Krishna Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

8.  Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.

Authors:  Rangarajan D Nadadur; Soban Umar; Gabriel Wong; Mansour Eghbali; Andrea Iorga; Humann Matori; Rod Partow-Navid; Mansoureh Eghbali
Journal:  J Appl Physiol (1985)       Date:  2012-05-24

Review 9.  Osteopontin and cardiovascular system.

Authors:  Hiroshi Okamoto
Journal:  Mol Cell Biochem       Date:  2006-11-30       Impact factor: 3.842

Review 10.  Clinical and Molecular Implications of Osteopontin in Heart Failure.

Authors:  Argen Mamazhakypov; Meerim Sartmyrzaeva; Akpay Sh Sarybaev; Ralph Schermuly; Akylbek Sydykov
Journal:  Curr Issues Mol Biol       Date:  2022-08-11       Impact factor: 2.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.